Agilent Technologies stock gains as recent revenue growth and guidance raise impress analysts
Published on 09/15/2026 at 21:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Agilent Technologies Inc. (ISIN US00846U1016) stock is trading around USD 146 on the New York Stock Exchange as of September 15, 2026, supported by solid recent quarterly growth and a raised full-year outlook that stood out in its research tools peer group.
Quarterly figures show solid growth
Agilent Technologies reported Q3 fiscal 2026 revenue of USD 1.88 billion, which represents an 8.1 percent increase compared with the same quarter a year earlier and exceeded analyst expectations by 1.9 percent, according to Yahoo Finance on September 15, 2026.
In the same Q3 fiscal 2026 period, Agilent generated earnings of USD 362 million, illustrating that the revenue growth is translating into improved profitability and underpinning its ability to raise full-year guidance, as highlighted by Yahoo Finance.
Guidance raise and analyst perspective
Agilent delivered the highest full-year guidance raise among its research tools peers following its Q3 fiscal 2026 report, which was accompanied by a strong beat on organic revenue estimates and full-year EPS guidance estimates, according to Yahoo Finance on September 15, 2026.
The guidance move has helped keep sentiment constructive even though the stock is down 6.2 percent since reporting and recently traded at USD 145.44 in that analysis snapshot, underscoring how investors are weighing the stronger outlook against valuation and broader market factors, as noted by Yahoo Finance.
Stock trades in the upper half of its yearly range
On September 15, 2026 Agilent Technologies stock closed at USD 146.80 on the NYSE, a marginal 0.09 percent decline from the previous close of USD 146.93, with the shares trading between an intraday low of USD 144.65 and a high of USD 148.50, based on data from Yahoo Finance as of September 15, 2026.
Over the past 52 weeks, Agilent shares have traded between a low of USD 108.35 and a high of USD 163.75, placing the current level around USD 146.80 in the upper half of that range and reflecting a gain of about 35.5 percent from the 52-week low while still standing roughly 10.4 percent below the 52-week high, according to price span data from Robinhood on September 15, 2026.
Valuation, market cap and trading activity
At a share price near USD 146.80, Agilent Technologies carries a market capitalization of about USD 41.39 billion as of September 15, 2026, which represents a 5.5 percent increase in market value for 2026 so far, according to CompaniesMarketCap.
The stock shows a trailing price-earnings multiple of about 28.93 and a dividend yield of 0.69 percent, indicating that investors are willing to pay a premium valuation for Agilent’s growth profile and recurring revenue mix in laboratory instruments and consumables, as detailed by Robinhood.
Momentum and technical levels
From a technical perspective, recent trading has left Agilent Technologies stock in a constructive uptrend, with the correction from a recent high of USD 163.75 down to around USD 146.80 amounting to about 10 percent, while key moving averages such as the 50-day level near USD 144.13 continue to support the shares, according to a chart analysis by Aktiencheck on September 15, 2026.
The same analysis cites an analyst price target of USD 174.95, which implies significant upside from the current region near USD 146.80 if the upward trend remains intact and Agilent can hold above key technical support zones, as highlighted by Aktiencheck.
Closing view on the stock
Agilent Technologies stock last closed at USD 146.80 on the NYSE on September 15, 2026, with the shares trading within a well-defined range and supported by a USD 41.39 billion market capitalization and recent double-digit revenue growth in Q3 fiscal 2026.
Agilent Technologies stock at a glance
- Company: Agilent Technologies Inc.
- ISIN: US00846U1016
- Ticker: A
- Trading venue: NYSE
- Price (as of September 15, 2026, 16:02): 146.80 USD
- Market capitalization: 41.39 billion USD (as of September 15, 2026)
- Sector / Industry: Life sciences tools and services
- Index membership: S&P 500
